chr19-11089513-T-G
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 3P and 1B. PM2PP4BS3_Supporting
This summary comes from the ClinGen Evidence Repository: The NM_000527.5 (LDLR):c.-36T>G variant is classified as Uncertain significance – insufficient evidence for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PM2, PP4 and BS3_Supporting as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on 28 October 2024.The supporting evidence is as follows:PM2: This variant is absent from gnomAD (gnomAD v4.1.0).PP4: Variant meets PM2, and is identified in one index case who fulfils DLCN criteria for probable FH after alternative causes of high cholesterol were excluded, reported in PMID 21538688 (Supplementary Table 2) by De Castro-Oros et al, 2011 from Universidad de Zaragoza, Spain.BS3_Supporting: Level 3 assay performed with luciferase reporter gene assay in HepG2 cells and there was no significant deference observed in gene expression comparing to wild-type construct, reported in PMID 21538688 by De Castro-Oros et al, 2011 from Universidad de Zaragoza, Spain. Level 3 assay performed with luciferase reporter gene assay in HepG2 cells showed 100% expression compared to wild-type, reported in PMID 31395865 by Kircher et al, 2019 from University of Washington, Seattle, USA. LINK:https://erepo.genome.network/evrepo/ui/classification/CA10584714/MONDO:0007750/013
Frequency
Consequence
NM_000527.5 5_prime_UTR
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000527.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LDLR | NM_000527.5 | MANE Select | c.-36T>G | 5_prime_UTR | Exon 1 of 18 | NP_000518.1 | |||
| LDLR-AS1 | NR_163945.1 | n.147A>C | non_coding_transcript_exon | Exon 1 of 1 | |||||
| LDLR | NM_001195798.2 | c.-36T>G | 5_prime_UTR | Exon 1 of 18 | NP_001182727.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LDLR | ENST00000558518.6 | TSL:1 MANE Select | c.-36T>G | 5_prime_UTR | Exon 1 of 18 | ENSP00000454071.1 | |||
| LDLR | ENST00000558013.5 | TSL:1 | c.-36T>G | 5_prime_UTR | Exon 1 of 18 | ENSP00000453346.1 | |||
| LDLR | ENST00000557958.1 | TSL:2 | n.51T>G | non_coding_transcript_exon | Exon 1 of 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hypercholesterolemia, familial, 1 Uncertain:2Benign:1
The NM_000527.5 (LDLR):c.-36T>G variant is classified as Uncertain significance – insufficient evidence for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PM2, PP4 and BS3_Supporting as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on 28 October 2024. The supporting evidence is as follows: PM2: This variant is absent from gnomAD (gnomAD v4.1.0). PP4: Variant meets PM2, and is identified in one index case who fulfils DLCN criteria for probable FH after alternative causes of high cholesterol were excluded, reported in PMID 21538688 (Supplementary Table 2) by De Castro-Oros et al, 2011 from Universidad de Zaragoza, Spain. BS3_Supporting: Level 3 assay performed with luciferase reporter gene assay in HepG2 cells and there was no significant deference observed in gene expression comparing to wild-type construct, reported in PMID 21538688 by De Castro-Oros et al, 2011 from Universidad de Zaragoza, Spain. Level 3 assay performed with luciferase reporter gene assay in HepG2 cells showed 100% expression compared to wild-type, reported in PMID 31395865 by Kircher et al, 2019 from University of Washington, Seattle, USA.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at